Opko Health, Inc. is a diversified healthcare enterprise headquartered in Miami, Florida, specializing in innovative pharmaceuticals and diagnostics across urology, endocrinology, and infectious diseases. With a strategic global presence in the United States, Ireland, and Spain, Opko leverages proprietary technologies and collaborations to address unmet medical needs and improve patient care. The company's dedication to innovation and an expanding product pipeline positions it as a crucial player in the healthcare sector, committed to advancing therapeutic solutions and enhancing patient outcomes. Show more

Location: 4400 BISCAYNE BOULEVARD, MIAMI, FL, UNITED STATES, 33137, Miami, FL, 33137, USA | Website: https://www.opko.com | Industry: DIAGNOSTICS & RESEARCH | Sector: HEALTHCARE

Market Cap

976.4M

52 Wk Range

$1.11 - $2.04

Previous Close

$1.23

Open

$1.24

Volume

3,384,661

Day Range

$1.23 - $1.25

Enterprise Value

939.8M

Cash

415.2M

Avg Qtr Burn

-34.65M

Insider Ownership

48.71%

Institutional Own.

25.43%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
NGENLA® Somatrogon Details Pediatric growth hormone deficiency	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Rayaldee (calcifediol ER capsules) Details Chronic kidney disease	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
OPK88003 (oxyntomodulin analog) (GLP-1R/GCGR agonist) Details Type 2 diabetes	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MDX2004 Details Advanced cancers	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MDX2001 (Tetraspecific LASER) Details Cancer, Solid tumor/s	Phase 1b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MDX2201 Details Epstein-Barr virus, Vaccine	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SAR441236 Details Human immunodeficiency virus	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Rayaldee Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.